Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

Overview of attention for article published in Biologics: Targets & Therapy, January 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source
twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 73 Dimensions

Readers on

mendeley: 58 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Ixekizumab for treating axial spondyloarthritis : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 21 Jul 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.